Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases

Archives of Toxicology

Volumn 72, Issue 9, 1998, Pages 580-587

  Worek, F ^a   Eyer, P ^b   Szinicz, L ^a  

^a Inst fur Pharmakol und Toxikol   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acetylcholinesterase; Butyrylchotinesterase; Cyclosarin; Inhibition; Reactivation

Indexed keywords

ACETYLCHOLINESTERASE; SARIN;

AGING; ARTICLE; CHOLINESTERASE INHIBITION; DRUG EFFECT; HUMAN; HUMAN CELL; INTOXICATION; PRIORITY JOURNAL; TOXICITY TESTING;

ACETYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; ERYTHROCYTES; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; TIME FACTORS;

EID: 0031694251     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050546     Document Type: Article

References (41)

1. Aldridge WN, Reiner E (1972) Enzyme inhibitors as substrates. North-Holland Publishing Co. Amsterdam
2. Ballantyne B, Marrs TC (1992) Overview of the biological and clinical aspects of organophosphates and carbamates. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth & Heinemann, Oxford, pp 3-14
3. Benschop HP, Keijer JH (1966) On the mechanism of ageing of phosphonylated cholinesterases. Biochim Biophys Acta 128: 586-588
4. Berry WK, Davies DR (1966) Factors influencing the rate of 'aging' in a series of alkyl methylphosphonyl-acetylcholinesterases. Biochem J 100: 572-576
5. Bismuth C, Inns RH, Marrs TC (1992) Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth & Heinemann, Oxford, pp 555-577
6. Bucht G, Puu G (1984) Aging and reactivatability of plaice cholinesterase inhibited by soman and its stereoisomers. Biochem Pharmacol 33: 3573-3577
7. Clement JG (1992) Efficacy of various oximes against GF (cyclohexylmethylphosphonofluoridate) poisoning in mice. Arch Toxicol 66: 143-144
8. Clement JG, Hansen AS, Boulet CA (1992) Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 66: 216-219
9. Clement JG, Bailey DG, Madill HD, Tran LT, Spence JD (1995) The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine. Biopharm Drug Dispos 16: 415-425
10. Coleman IW, Patton GE, Bannard RAB (1968) Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of Parpanit with oximes in the treatment of organophosphorus poisoning. Can J Physiol Pharmacol 46: 109-117
11. Dawson RM (1994) Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14: 317-331
12. de Jong LPA, Wolring GZ (1978) Reactivation and aging of cyclopentyl methylphosphonylated acetylcholinesterase in the presence of some 1-alkyl-2-hydroxyiminomethyl-pyridinium salts. Biochem Pharmacol 27: 2911-2917
13. de Jong LPA, Wolring GZ (1984) Stereospecific reactivation by some Hagedorn-oximes of acetycholinesterases from various species including man inhibited by soman. Biochem Pharmacol 33: 1119-1125
14. de Jong LPA, Verhagen AAV, Langenberg JP, Hagedorn I, Löffler M (1989) The bispyridinium-dioxime HLö-7: a potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman. Biochem Pharmacol 38: 633-640
15. Ellman GL, Courtney KD, Anders V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95
16. Ever P, Hagedorn I, Klimmek R, Lippstreu P, Löffler M, Oldiges H, Spöhrer U, Steidl I, Szinicz L, Worek F (1992) HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases. Arch Toxicol 66: 603-621
17. Gray PJ, Dawson RM (1987) Kinetic constants for the inhibition of eel and rabbit brain acetylcholinesterase by some organophosphates and carbamates of military significance. Toxicol Appl Pharmacol 91: 140-144
18. Green AL, Smith HJ (1958) The reactivation of cholinesterase inhibited with organophosphorus compounds. Biochem J 68: 28-35
19. Kassa J, Bajgar J (1995) Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl methyl-phosphonofluoridate (GF) in rats. Hum Exp Toxicol 14: 923-928
20. Keijer JH, Wolring GZ, de Jong LPA (1974) Effect of pH, temperature and ionic strength on the aging of phosphonylated cholinesterases. Biochim Biophys Acta 334: 146-155
21. Koplovitz I, Gresham VC, Dochterman LW, Kaminskis A, Stewart JR (1992) Evaluation of the toxicity, pathology and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch Toxicol 66: 622-628
22. Levy D, Ashani Y (1986) Synthesis and in vitro properties of a powerful quaternary methylphosphonate inhibitor of acetylcholinesterase - a new marker in blood-brain barrier research. Biochem Pharmacol 35: 1079-1085
23. Lundy PM, Hansen AS, Hand BT, Boulet CA (1992) Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology 72: 99-105
24. Luo C, Liang J (1997) Evaluation of combined toxic effects of GB/ GF and efficacy of Jielin injection against combined poisoning in mice. Toxicol Lett 92: 195-200
25. Mast U (1997) Reaktivierung der Erythrozyten-Acetylcholinesterase durch Oxime. Thesis, Universität München
26. Nenner M (1971) Bestimmung der molaren Konzentration von Acetylcholinesterase durch Phosphorylierung mit Paraoxon oder Soman. Biochim Biophys Acta 242: 371-380
27. Nozaki H, Aikawa N, Shinozawa Y, Hori S, Fujishima S, Takuma K, Sagoh M (1995a) Sarin poisoning in Tokyo subway. Lancet 345: 980-981
28. Nozaki H, Aikawa N, Fujishima S, Suzuki M, Shinozawa Y, Hori S, Nogawa S (1995b) A case of VX poisoning and the difference from sarin. Lancet 346: 698-699
29. Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Mitsuhashi A, Kumuda K, Tanaka K, Hinohara S (1996) Report of 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 28: 129-135
30. Schoene K, Strake EM (1971) Reaktivierung von Diäthylphosphoryl-Acetylcholinesterase - Affinität und Reaktivität einiger Pyridiniumoxime. Biochem Pharmacol 20: 1041-1051
31. Shafferman A, Ordentlich A, Barak D, Stein D, Ariel N, Velan B (1996) Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre. Biochem J 318: 833-840
32. Sidell FR (1992) Clinical considerations in nerve agent intoxication. In: Somani SM (ed) Chemical warfare agents. Academic Press, San Diego, pp 155-194
33. Sidell FR, Groff WA (1970) Toxogonin: blood levels and side effects after intramuscular administration in man. J Pharm Sci 59: 793-797
34. Sidell FR, Groff WA (1971) Intramuscular amd intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man. J Pharm Sci 60: 1224-1228
35. Skrinjaric-Spoljar M, Simeon V, Reiner E (1973) Spontaneous reactivation and aging of dimethylphosphorylated acetylcholinesterase and cholinesterase. Biochim Biophys Acta 315: 363-369
36. Su CT, Wang PH, Lui RF, Shih JH, Ma C, Lin CH, Liu CY, Wu MT (1986) Kinetic studies and structure-activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Fundam Appl Toxicol 6: 506-514
37. Suzuki J, Kohno T, Tsukagosi M, Furuhata T, Yamazaki K (1997) Eighteen cases exposed to sarin in Matsumoto, Japan. Intern Med 36: 466-470
38. Wang EIC, Braid PE (1967) Oxime reactivation of diethylphosphoryl human serum cholinesterase. J Biol Chem 242: 2683-2687
39. Worek F, Kirchner T, Bäcker M, Szinicz L (1996) Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch Toxicol 70: 497-503
40. Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Ever P (1997) Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16: 466-472
41. Worek F, Widmann R, Knopff O, Szinicz L (1998) Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72: 237-243